Company FORN EUROPAR

Equities

FRBN

KYG3619H1020

Delayed Nasdaq Other stock markets 20:39:15 05/07/2024 BST			5-day change	1st Jan Change
9.051 ^USD	+0.68%		+12.38%	-58.52%

2023	EnGene, Inc. completed the acquisition of Forbion European Acquisition Corp. from a group of shareholders in a reverse merger transaction.	CI
2023	Forbion European Acquisition Corp.(NasdaqGM:FRBN) dropped from NASDAQ Composite Index	CI

Business Summary

Forbion European Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination. The Company intend to focus its search on lifestyle, technology, healthcare and wellness sectors. The Company has not commenced any operations nor generated any revenue.

Company contact information

Forbion European Acquisition Corp.

4001 Kennett Pike Suite 302

19807, Wilmington

http://www.forbion.com/en/feac/

Sector

This company's sector is not yet available